ITEMS IN AFP WITH KEYWORD:
Family Planning and Contraception
The Centers for Disease Control and Prevention (CDC) first published the U.S. Selected Practice Recommendations for Contraceptive Use (U.S. SPR) in 2013 to provide direction for safe and effective use of contraceptive methods. These guidelines update the 2013 report.
Dec 1, 2016 Issue
CDC Updates Eligibility Criteria for Contraceptive Use [Practice Guidelines]
The Centers for Disease Control and Prevention (CDC) first published the U.S. Medical Eligibility Criteria for Contraceptive Use, which is a companion document to the U.S. Selected Practice Recommendations for Contraceptive Use, in 2010 to provide guidelines on safely using a variety of contraceptiv...
Nov 1, 2016 Issue
The Risk of MI and Ischemic Stroke with Combined Oral Contraceptives [Cochrane for Clinicians]
The overall risk of MI and ischemic stroke is increased in women who use combined oral contraceptives. The relative risk of MI and ischemic stroke increases as estrogen dose rises, increasing by 60% with doses of 20 mcg and more than doubling when doses of 50 mcg or more are used.
Although there is risk with any current oral contraceptive combination, those that contain lower doses of estrogen, and levonorgestrel instead of desogestrel or gestodene, are associated with the least risk of ischemic stroke, myocardial infarction (MI), or pulmonary embolism (PE). These safer products are older so are often less expensive.
Sep 15, 2016 Issue
AAFP Releases Position Paper on Preconception care [Practice Guidelines]
The American Academy of Family Physicians (AAFP) has released a position paper providing evidence-based recommendations that address reproductive health care.
Use of hormonal contraception does not appear to shorten breastfeeding duration or negatively impact infant growth, based on inconsistent evidence of moderate quality. It is unclear if hormonal contraception negatively impacts breast milk volume or composition. Overall, there was limited evidence re...
OTC access to oral contraceptives must be one component of a multipronged strategy aimed at improving access to all contraceptive methods to help women better plan their pregnancies using the method best for them. The efforts by professional societies to articulate the safety and effectiveness of OT...
Review the CDC’s comprehensive recommendations on providing family planning services, including how to help patients choose the most effective and appropriate contraceptive method.
Mar 1, 2015 Issue
Risk of Venous Thromboembolism with Use of Combined Oral Contraceptives [Cochrane for Clinicians]
All combined oral contraceptives increase VTE risk. The risk is greater for those containing desogestrel, drospirenone, gestodene (not available in the United States), and cyproterone acetate (not available in the United States) when compared with levonorgestrel. All combined oral contraceptives are effective in preventing pregnancy.
Nov 1, 2014 Issue
Oral Contraceptives Are Not an Effective Treatment for Ovarian Cysts [Cochrane for Clinicians]
Oral contraceptives are not an effective treatment for ovarian cysts, whether the cysts are spontaneous or associated with medically induced ovulation. Most cysts resolve without intervention within two to three months. Those that do not resolve in this time frame are more likely to be pathologic in...